Celularity warns 'substantial portion' of staff about possible layoffs after reviewing cell therapy strategy

Celgene spinout Celularity has left an ax dangling over a “substantial portion” of its workforce. While the cell therapy firm is “hopeful” it can avoid significant layoffs, it has told many staffers their jobs are on the line as it pursues an updated strategy.